TrialThe New England journal of medicine2014
A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis.
Talmadge E King et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1,952 papers cite itlatest 60 shown
this paperpooled ittrialcites it